Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Community-Institutional Relations | 2 | 2020 | 204 | 0.830 |
Why?
|
Indians, North American | 2 | 2020 | 355 | 0.680 |
Why?
|
Antitubercular Agents | 2 | 2023 | 1320 | 0.530 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2023 | 912 | 0.510 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 941 | 0.400 |
Why?
|
Particulate Matter | 8 | 2017 | 2530 | 0.360 |
Why?
|
DNA, Mitochondrial | 4 | 2019 | 817 | 0.340 |
Why?
|
Tuberculosis, Pulmonary | 3 | 2022 | 810 | 0.280 |
Why?
|
Epigenesis, Genetic | 6 | 2019 | 3647 | 0.270 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 5751 | 0.240 |
Why?
|
Clofazimine | 1 | 2023 | 33 | 0.230 |
Why?
|
Air Pollution | 5 | 2017 | 2286 | 0.230 |
Why?
|
DNA Methylation | 6 | 2019 | 4286 | 0.200 |
Why?
|
Fetal Blood | 2 | 2019 | 1318 | 0.200 |
Why?
|
Mycobacterium tuberculosis | 2 | 2022 | 1832 | 0.180 |
Why?
|
New Mexico | 1 | 2019 | 86 | 0.180 |
Why?
|
Arizona | 1 | 2019 | 108 | 0.180 |
Why?
|
Utah | 1 | 2019 | 126 | 0.180 |
Why?
|
Antibiotics, Antitubercular | 1 | 2019 | 104 | 0.170 |
Why?
|
Vitamin B 6 | 2 | 2017 | 237 | 0.170 |
Why?
|
Tuberculosis | 2 | 2022 | 1912 | 0.170 |
Why?
|
Environmental Exposure | 3 | 2017 | 4234 | 0.160 |
Why?
|
Vitamin B 12 | 2 | 2017 | 527 | 0.150 |
Why?
|
Folic Acid | 3 | 2019 | 1300 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11725 | 0.140 |
Why?
|
Heart Rate | 2 | 2017 | 4091 | 0.130 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.120 |
Why?
|
Vitamin B Complex | 1 | 2017 | 288 | 0.120 |
Why?
|
Mastectomy, Modified Radical | 1 | 2014 | 62 | 0.120 |
Why?
|
Air Pollutants | 3 | 2017 | 2817 | 0.120 |
Why?
|
Soot | 1 | 2015 | 232 | 0.120 |
Why?
|
Aging | 4 | 2016 | 8664 | 0.120 |
Why?
|
Lead | 1 | 2019 | 852 | 0.110 |
Why?
|
DNA | 2 | 2019 | 7301 | 0.110 |
Why?
|
Birth Weight | 2 | 2019 | 2069 | 0.110 |
Why?
|
CpG Islands | 4 | 2019 | 1172 | 0.110 |
Why?
|
Bradycardia | 1 | 2015 | 307 | 0.110 |
Why?
|
Toll-Like Receptor 2 | 1 | 2015 | 354 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1035 | 0.100 |
Why?
|
Autonomic Nervous System | 1 | 2017 | 671 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2019 | 961 | 0.100 |
Why?
|
Flavonoids | 1 | 2015 | 443 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1457 | 0.100 |
Why?
|
Vehicle Emissions | 1 | 2015 | 665 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2019 | 1179 | 0.090 |
Why?
|
Heart Conduction System | 1 | 2015 | 1047 | 0.080 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 956 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.080 |
Why?
|
Oxidative Stress | 2 | 2019 | 3086 | 0.080 |
Why?
|
Peru | 2 | 2022 | 881 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1972 | 0.080 |
Why?
|
Particle Size | 3 | 2017 | 1642 | 0.080 |
Why?
|
Gestational Age | 1 | 2016 | 3493 | 0.080 |
Why?
|
Occupational Diseases | 1 | 2016 | 1471 | 0.080 |
Why?
|
Placenta | 1 | 2017 | 1698 | 0.080 |
Why?
|
Models, Genetic | 1 | 2017 | 3494 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3022 | 0.070 |
Why?
|
Aged | 9 | 2020 | 163280 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57776 | 0.060 |
Why?
|
Middle Aged | 10 | 2020 | 213383 | 0.060 |
Why?
|
Humans | 22 | 2023 | 744343 | 0.060 |
Why?
|
Male | 14 | 2020 | 350118 | 0.060 |
Why?
|
Female | 14 | 2020 | 380194 | 0.060 |
Why?
|
Mitochondria | 1 | 2015 | 3520 | 0.050 |
Why?
|
Fetal Development | 2 | 2019 | 767 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6256 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2029 | 0.050 |
Why?
|
Adult | 10 | 2020 | 214055 | 0.050 |
Why?
|
Epigenomics | 2 | 2017 | 903 | 0.050 |
Why?
|
Cognition | 1 | 2018 | 6770 | 0.050 |
Why?
|
Blood Pressure | 1 | 2015 | 8554 | 0.040 |
Why?
|
Pregnancy | 5 | 2020 | 29144 | 0.040 |
Why?
|
Prospective Studies | 6 | 2020 | 53288 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10638 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 633 | 0.040 |
Why?
|
Cohort Studies | 5 | 2018 | 40561 | 0.040 |
Why?
|
Mexico | 1 | 2019 | 690 | 0.040 |
Why?
|
Diet | 1 | 2015 | 7939 | 0.040 |
Why?
|
Hypertension | 1 | 2015 | 8480 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 793 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2019 | 25625 | 0.030 |
Why?
|
Pilot Projects | 2 | 2017 | 8324 | 0.030 |
Why?
|
Feces | 1 | 2019 | 1401 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2017 | 1590 | 0.030 |
Why?
|
Italy | 1 | 2014 | 832 | 0.030 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 257 | 0.030 |
Why?
|
Young Adult | 4 | 2020 | 56430 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1106 | 0.030 |
Why?
|
Program Evaluation | 1 | 2020 | 2488 | 0.020 |
Why?
|
Fetus | 1 | 2019 | 1880 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 986 | 0.020 |
Why?
|
Immunomodulation | 1 | 2015 | 541 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1341 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15165 | 0.020 |
Why?
|
Fasting | 1 | 2016 | 1593 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12261 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1312 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1770 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1372 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20822 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2019 | 2408 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2924 | 0.020 |
Why?
|
Menopause | 1 | 2014 | 1626 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2014 | 3479 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9687 | 0.020 |
Why?
|
Electrocardiography | 1 | 2017 | 6442 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39050 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8987 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5720 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13989 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12720 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12354 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 9959 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 77449 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9239 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40075 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29063 | 0.010 |
Why?
|
HIV Infections | 1 | 2020 | 16718 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11524 | 0.010 |
Why?
|
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_